Comments
Loading...

Nutrien Analyst Ratings

NTRNYSE
Logo brought to you by Benzinga Data
$57.90
0.440.77%
At close: -
$57.00
-0.90-1.55%
After Hours: May 16, 5:41 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$86.00
Lowest Price Target1
$50.00
Consensus Price Target1
$64.88

Nutrien Analyst Ratings and Price Targets | NYSE:NTR | Benzinga

Nutrien Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Nutrien Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
3
Feb
1
1
Mar
1
1
Apr
3
3
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barclays
B of A Securities
Scotiabank
Oppenheimer
Wells Fargo

1calculated from analyst ratings

Analyst Ratings for Nutrien

Buy NowGet Alert
05/14/2025Buy Now—Barclays
Benjamin Theurer62%
$59 → $61MaintainsEqual-WeightGet Alert
05/14/2025Buy Now—B of A Securities
Steve Byrne53%
$60 → $63MaintainsBuyGet Alert
05/14/2025Buy Now—Scotiabank
Ben Isaacson47%
$62 → $62DowngradeSector Outperform → Sector PerformGet Alert
05/13/2025Buy Now—Oppenheimer
Kristen Owen58%
$58 → $63MaintainsOutperformGet Alert
05/12/2025Buy Now—Wells Fargo
Richard Garchitorena51%
$56 → $59MaintainsEqual-WeightGet Alert
05/12/2025Buy Now—RBC Capital
Andrew Wong45%
$60 → $65MaintainsOutperformGet Alert
05/09/2025Buy Now—Goldman Sachs
Duffy Fischer58%
$53 → $59MaintainsSellGet Alert
05/08/2025Buy Now—UBS
Eric Beaumont70%
$52 → $56MaintainsNeutralGet Alert
04/22/2025Buy Now—Oppenheimer
Kristen Owen58%
$60 → $58MaintainsOutperformGet Alert
04/16/2025Buy Now—UBS
Eric Beaumont70%
$54 → $52MaintainsNeutralGet Alert
03/13/2025Buy Now—Goldman Sachs
Duffy Fischer58%
→ $53Initiates → SellGet Alert
03/05/2025Buy Now—Barclays
Benjamin Theurer62%
$56 → $59MaintainsEqual-WeightGet Alert
02/25/2025Buy Now—CIBC—$64 → $66MaintainsOutperformerGet Alert
02/24/2025Buy Now—RBC Capital
Andrew Wong45%
$60 → $60ReiteratesOutperform → OutperformGet Alert
02/24/2025Buy Now—Scotiabank
Ben Isaacson47%
$60 → $62MaintainsSector OutperformGet Alert
02/21/2025Buy Now—Wells Fargo
Richard Garchitorena51%
$53 → $56MaintainsEqual-WeightGet Alert
02/20/2025Buy Now—Mizuho
Christopher Parkinson55%
$52 → $55MaintainsNeutralGet Alert
02/20/2025Buy Now—UBS
Eric Beaumont70%
$53 → $54MaintainsNeutralGet Alert
02/10/2025Buy Now—Scotiabank
Ben Isaacson47%
$59 → $60MaintainsSector OutperformGet Alert
01/28/2025Buy Now—UBS
Joshua Spector54%
$51 → $53MaintainsNeutralGet Alert
01/28/2025Buy Now—Wells Fargo
Richard Garchitorena51%
$52 → $53MaintainsEqual-WeightGet Alert
01/27/2025Buy Now—Piper Sandler
Charles Neivert46%
$58 → $63MaintainsOverweightGet Alert
01/21/2025Buy Now—Barclays
Benjamin Theurer62%
$55 → $56DowngradeOverweight → Equal-WeightGet Alert
01/13/2025Buy Now—Piper Sandler
Charles Neivert46%
$50 → $58UpgradeUnderweight → OverweightGet Alert
01/13/2025Buy Now—JP Morgan
Jeffrey Zekauskas66%
$40 → $50UpgradeUnderweight → NeutralGet Alert
12/12/2024Buy Now—Oppenheimer
Kristen Owen58%
→ $60Initiates → OutperformGet Alert
12/10/2024Buy Now—CIBC—$60 → $55Assumes → OutperformerGet Alert
12/03/2024Buy Now—Raymond James
Steve Hansen63%
$58 → $60UpgradeMarket Perform → OutperformGet Alert
10/10/2024Buy Now—UBS
Joshua Spector54%
$66 → $51DowngradeBuy → NeutralGet Alert
09/24/2024Buy Now—Wells Fargo
Richard Garchitorena51%
$62 → $50DowngradeOverweight → Equal-WeightGet Alert
09/20/2024Buy Now—RBC Capital
Andrew Wong45%
$60 → $60ReiteratesOutperform → OutperformGet Alert
09/10/2024Buy Now—Goldman Sachs
Adam Samuelson57%
$69 → $53DowngradeBuy → NeutralGet Alert
08/16/2024Buy Now—Barclays
Benjamin Theurer62%
$68 → $55MaintainsOverweightGet Alert
08/12/2024Buy Now—RBC Capital
Andrew Wong45%
$60 → $60ReiteratesOutperform → OutperformGet Alert
08/12/2024Buy Now—Scotiabank
Ben Isaacson47%
$66 → $59MaintainsSector OutperformGet Alert
08/09/2024Buy Now—BMO Capital
Joel Jackson50%
$80 → $75MaintainsOutperformGet Alert
08/08/2024Buy Now—Mizuho
Christopher Parkinson55%
$55 → $52MaintainsNeutralGet Alert
07/16/2024Buy Now—Wells Fargo
Richard Garchitorena51%
$68 → $66MaintainsOverweightGet Alert
07/15/2024Buy Now—RBC Capital
Andrew Wong45%
$70 → $60MaintainsOutperformGet Alert
07/09/2024Buy Now—UBS
Joshua Spector54%
$67 → $66MaintainsBuyGet Alert
06/11/2024Buy Now—Piper Sandler
Charles Neivert46%
$56 → $55MaintainsUnderweightGet Alert
05/17/2024Buy Now—Piper Sandler
Charles Neivert46%
$54 → $56MaintainsUnderweightGet Alert
05/17/2024Buy Now—Mizuho
Christopher Parkinson55%
$54 → $56MaintainsUnderweightGet Alert
05/10/2024Buy Now—Wells Fargo
Richard Garchitorena51%
$67 → $68MaintainsOverweightGet Alert
05/09/2024Buy Now—Mizuho
Christopher Parkinson55%
$54 → $59MaintainsNeutralGet Alert
04/29/2024Buy Now—Berenberg
Aron Ceccarelli53%
$60 → $66UpgradeHold → BuyGet Alert
03/26/2024Buy Now—Jefferies
Laurence Alexander75%
→ $62Initiates → BuyGet Alert
03/01/2024Buy Now—Wolfe Research
Chris Parkinson79%
—Initiates → OutperformGet Alert
02/29/2024Buy Now—Piper Sandler
Charles Neivert46%
$68 → $54DowngradeNeutral → UnderweightGet Alert
02/26/2024Buy Now—Wells Fargo
Richard Garchitorena51%
$77 → $69MaintainsOverweightGet Alert
02/23/2024Buy Now—RBC Capital
Andrew Wong45%
$75 → $70MaintainsOutperformGet Alert
02/23/2024Buy Now—JP Morgan
Jeffrey Zekauskas66%
$58 → $48DowngradeNeutral → UnderweightGet Alert
02/01/2024Buy Now—Goldman Sachs
Adam Samuelson57%
$88 → $78MaintainsBuyGet Alert
01/19/2024Buy Now—Stifel
Vincent Anderson74%
$72 → $75MaintainsBuyGet Alert
01/12/2024Buy Now—Raymond James
Steve Hansen63%
$80 → $65DowngradeOutperform → Market PerformGet Alert
11/14/2023Buy Now—Barclays
Benjamin Theurer62%
$64 → $68UpgradeUnderweight → OverweightGet Alert
11/06/2023Buy Now—JP Morgan
Jeffrey Zekauskas66%
$70 → $58DowngradeOverweight → NeutralGet Alert
11/03/2023Buy Now—RBC Capital
Andrew Wong45%
$85 → $80MaintainsOutperformGet Alert
08/14/2023Buy Now—Barclays
Benjamin Theurer62%
$70 → $68DowngradeOverweight → UnderweightGet Alert
08/08/2023Buy Now—RBC Capital
Andrew Quail32%
→ $85ReiteratesOutperform → OutperformGet Alert
08/07/2023Buy Now—Piper Sandler
Charles Neivert46%
$70 → $73MaintainsNeutralGet Alert
08/04/2023Buy Now—Mizuho
Christopher Parkinson55%
$74 → $73MaintainsNeutralGet Alert
07/31/2023Buy Now—TD Cowen
Michael Tupholme39%
$72 → $83UpgradeHold → BuyGet Alert
07/26/2023Buy Now—HSBC
Santhosh Seshadri71%
$81 → $72MaintainsHoldGet Alert
07/25/2023Buy Now—Morgan Stanley
Vincent Sinisi72%
$70 → $70ReiteratesEqual-Weight → Equal-WeightGet Alert
07/24/2023Buy Now—Wells Fargo
Richard Garchitorena51%
$62 → $82UpgradeEqual-Weight → OverweightGet Alert
07/19/2023Buy Now—Morgan Stanley
Vincent Sinisi72%
$70 → $70ReiteratesEqual-Weight → Equal-WeightGet Alert
07/18/2023Buy Now—Goldman Sachs
Adam Samuelson57%
$136 → $121MaintainsBuyGet Alert
06/08/2023Buy Now—B of A Securities
Steve Byrne53%
$94 → $85MaintainsBuyGet Alert
06/01/2023Buy Now—Barclays
Benjamin Theurer62%
$80 → $70MaintainsOverweightGet Alert
05/30/2023Buy Now—Morgan Stanley
Vincent Sinisi72%
$80 → $70MaintainsEqual-WeightGet Alert
05/19/2023Buy Now—JP Morgan
Jeffrey Zekauskas66%
$92 → $78MaintainsOverweightGet Alert
05/18/2023Buy Now—Piper Sandler
Charles Neivert46%
$82 → $70MaintainsNeutralGet Alert
05/17/2023Buy Now—Berenberg
Aron Ceccarelli53%
$92 → $49DowngradeBuy → HoldGet Alert
05/16/2023Buy Now—BMO Capital
Joel Jackson50%
$110 → $90MaintainsOutperformGet Alert
05/15/2023Buy Now—Wells Fargo
Richard Garchitorena51%
$82 → $62MaintainsEqual-WeightGet Alert
05/12/2023Buy Now—RBC Capital
Andrew Quail32%
$100 → $95MaintainsOutperformGet Alert
05/12/2023Buy Now—Raymond James
Steve Hansen63%
→ $85UpgradeMarket Perform → OutperformGet Alert
05/12/2023Buy Now—Mizuho
Christopher Parkinson55%
$79 → $75MaintainsNeutralGet Alert
05/12/2023Buy Now—Barclays
Benjamin Theurer62%
$93 → $80MaintainsOverweightGet Alert
05/11/2023Buy Now—Credit Suisse
Edlain Rodriguez67%
$70 → $60ReiteratesUnderperform → UnderperformGet Alert
04/19/2023Buy Now—Goldman Sachs
Adam Samuelson57%
$119 → $106MaintainsBuyGet Alert
04/14/2023Buy Now—Barclays
Benjamin Theurer62%
$95 → $93MaintainsOverweightGet Alert
04/12/2023Buy Now—Morgan Stanley
Vincent Sinisi72%
$91 → $80MaintainsEqual-WeightGet Alert
04/10/2023Buy Now—Scotiabank
Ben Isaacson47%
$95 → $90UpgradeSector Perform → Sector OutperformGet Alert
04/06/2023Buy Now—UBS
Joshua Spector54%
$100 → $99MaintainsBuyGet Alert
03/28/2023Buy Now—Erste Group
Hans Engel64%
—DowngradeBuy → HoldGet Alert
02/23/2023Buy Now—JP Morgan
Jeffrey Zekauskas66%
→ $92MaintainsOverweightGet Alert
02/21/2023Buy Now—RBC Capital
Andrew Quail32%
$115 → $110MaintainsOutperformGet Alert
02/21/2023Buy Now—HSBC
Santhosh Seshadri71%
$83 → $81MaintainsHoldGet Alert
02/17/2023Buy Now—Wells Fargo
Richard Garchitorena51%
$80 → $82MaintainsEqual-WeightGet Alert
02/16/2023Buy Now—UBS
Joshua Spector54%
$103 → $100MaintainsBuyGet Alert
02/16/2023Buy Now—Credit Suisse
Edlain Rodriguez67%
$65 → $70MaintainsUnderperformGet Alert
02/08/2023Buy Now—TD Securities
Michael Tupholme39%
—DowngradeBuy → HoldGet Alert
02/03/2023Buy Now—Raymond James
Steve Hansen63%
—DowngradeOutperform → Market PerformGet Alert
01/30/2023Buy Now—RBC Capital
Andrew Wong45%
$120 → $115MaintainsOutperformGet Alert
01/20/2023Buy Now—Citigroup
PJ Juvekar68%
$87 → $86MaintainsBuyGet Alert
01/19/2023Buy Now—Wells Fargo
Richard Garchitorena51%
→ $80Initiates → Equal-WeightGet Alert
01/13/2023Buy Now—JP Morgan
Jeffrey Zekauskas66%
$98 → $95MaintainsOverweightGet Alert
01/12/2023Buy Now—Mizuho
Christopher Parkinson55%
$93 → $91MaintainsNeutralGet Alert

FAQ

Q

What is the target price for Nutrien (NTR) stock?

A

The latest price target for Nutrien (NYSE:NTR) was reported by Barclays on May 14, 2025. The analyst firm set a price target for $61.00 expecting NTR to rise to within 12 months (a possible 7.02% upside). 41 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Nutrien (NTR)?

A

The latest analyst rating for Nutrien (NYSE:NTR) was provided by Barclays, and Nutrien maintained their equal-weight rating.

Q

When was the last upgrade for Nutrien (NTR)?

A

The last upgrade for Nutrien Ltd happened on January 13, 2025 when Piper Sandler raised their price target to $58. Piper Sandler previously had an underweight for Nutrien Ltd.

Q

When was the last downgrade for Nutrien (NTR)?

A

The last downgrade for Nutrien Ltd happened on May 14, 2025 when Scotiabank changed their price target from $62 to $62 for Nutrien Ltd.

Q

When is the next analyst rating going to be posted or updated for Nutrien (NTR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nutrien, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nutrien was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.

Q

Is the Analyst Rating Nutrien (NTR) correct?

A

While ratings are subjective and will change, the latest Nutrien (NTR) rating was a maintained with a price target of $59.00 to $61.00. The current price Nutrien (NTR) is trading at is $57.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.